An economic model comparing different types of genetic testing in metastatic non-small-cell lung cancer (NSCLC) found that using next-generation sequencing (NGS) to test for all known lung cancer-related gene changes at the time of diagnosis was more cost-effective and faster than testing one or a limited number of genes at a time.
from Top Health News – ScienceDaily http://bit.ly/2rQOyvm
from Tumblr http://bit.ly/2rRRqYS
No comments:
Post a Comment